ArticleIJU case reports2026

Drastic Response to Olaparib in a Patient With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA2 Alterations and Near-Threshold Tumor Mutational Burden.

Kotaro Yokota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.